Peripheral blood CD4+ T cells and intestinal lamina propria mononuclear cells contribute to viremia following an analytical treatment interruption: a follow-up analysis of the panobinostat trial

• K. Barton,
• B. Hiener,
• A. Winckelmann,
• T. Aagaard Rasmussen,
• M. Tolstrup,
• W. Shao,
• R. Olesen,
• P.W. Denton,
• A. Solomon,
• L. Østergaard,
• S.R. Lewin,
• O. Schmeltz Søgaard,
• S. Palmer

Affiliations

K. Barton

Centre for Virus Research, Westmead Millennium Institute, Westmead, Australia

B. Hiener

Centre for Virus Research, Westmead Millennium Institute, Westmead, Australia

A. Winckelmann

Centre for Virus Research, Westmead Millennium Institute, Westmead, Australia; Department of Infectious Diseases, Aarhus University Hospital, Denmark

T. Aagaard Rasmussen

Department of Infectious Diseases, Aarhus University Hospital, Denmark

M. Tolstrup

Department of Infectious Diseases, Aarhus University Hospital, Denmark

W. Shao

Advanced Biomedical Computing Center, Leidos Biomedical Research, USA; Frederick National Laboratory for Cancer Research (FNLCR), Frederick, MD, USA

R. Olesen

Department of Infectious Diseases, Aarhus University Hospital, Denmark

P.W. Denton

Department of Infectious Diseases, Aarhus University Hospital, Denmark

A. Solomon

Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne

L. Østergaard

Department of Infectious Diseases, Aarhus University Hospital, Denmark

S.R. Lewin

Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne; Department of Infectious Diseases, Alfred Hospital, Monash University, Melbourne, Australia

O. Schmeltz Søgaard

Department of Infectious Diseases, Aarhus University Hospital, Denmark

S. Palmer

Centre for Virus Research, Westmead Millennium Institute, Westmead, Australia